65,437 trials
Liver Transplantation · Postreperfusion Syndrome
Primary: Number of Participants With Moderate and Severe Postreperfusion Syndrome (PRS) — 15; 25 participants
Chronic Idiopathic Urticaria
Primary: Change in the Urticaria Activity Score (UAS) From Baseline to the Final Week for Desloratadine 5 mg Versus Desloratadine 20 mg — -1.0; -1.0; -1.1; 2.9 Units on a scale…
Allergic Rhinitis · Asthma
Primary: The Change of the Rhinasthma Global Summary Score From Baseline to Endpoint After 28 Days of Treatment. — 25.3; 26.7; -10.3; 0.4 units on a scale — p=0.001
Lymphangioleiomyomatosis · Lymphangiomyomas · Pleural Effusions
Primary: Number of Participants With a Reduction in Total Tumor Volume of at Least 20%. — 0 Participants
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 0.54; 0.55 ng/mL
Growth Disorders · Insulin-Like Growth Factor-1 Deficiency
Primary: Height Velocity During the First Year - Intent to Treat (ITT)Population — 5.2; 6.9; 7.7 cm/yr — p=<0.0001
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 0.61; 0.54 ng/mL
Gastric Acid · Human Experimentation
Primary: Change From Baseline in Median 24-hour Intragastric pH on the 7th Day of Drug Administration — 4.575; 3.980; 3.165; 2.550 pH scale
Orthomyxoviridae Infection · Influenza · Myxovirus Infection
Primary: Geometric Mean Titers (GMTs) of Hemagglutination Inhibition Antibody Titers Pre- and Post-vaccination With Fluzone® High Dose or Standard Fluzone® Vaccines. — 28.25…
Gastric Acid · Human Experimentation
Primary: Change From Baseline in Median 24-hour Intragastric pH on the 7th Day of Drug Administration — 3.250; 4.160; 2.180; 2.900 pH scale
Obscure Gastrointestinal Bleeding · Angiodysplasia · Gastric Antral Vascular Ectasia
Primary: Participants Whose Rebleeds Decreased From Baseline by ≥ 50% at 12 Months — 20; 1 participants — p=0.00000013
Detrusor Hyperreflexia
Primary: Average Number of Catheterizations Without Leaking Per Day — 2.4; 1.5 Number of Dry Catheterizations per Day
Skin Infections, Bacterial
Primary: Number of Participants With Measurable Plasma Concentrations, by Age Group — 36; 17; 10; 9 participants
Major Depressive Disorder
Primary: Number of Patients Achieving Remission — 554; 207 participants
Low Back Pain
Primary: Numbers and Types of Adverse Events (Only Number of Events is Reported in This Section - See Adverse Events Section for Further Detail) — 17 Events